AMERIPRISE FINANCIAL INC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$4,332,421
-37.1%
270,101
-9.1%
0.00%
-50.0%
Q2 2023$6,888,005
-4.6%
297,153
-4.4%
0.00%0.0%
Q1 2023$7,222,044
+56.2%
310,893
-2.4%
0.00%0.0%
Q4 2022$4,624,000
-49.5%
318,642
-33.6%
0.00%
-33.3%
Q3 2022$9,161,000
-28.2%
480,127
-31.6%
0.00%
-25.0%
Q2 2022$12,761,000
-29.7%
702,218
-2.5%
0.00%
-20.0%
Q1 2022$18,155,000
-8.0%
720,426
+0.8%
0.01%0.0%
Q4 2021$19,730,000
-6.6%
714,864
+9.3%
0.01%
-28.6%
Q3 2021$21,116,000
+98.6%
654,069
+88.1%
0.01%
+133.3%
Q2 2021$10,634,000
+0.7%
347,730
+0.3%
0.00%
-25.0%
Q1 2021$10,557,000
+62.8%
346,669
+5.7%
0.00%
+100.0%
Q4 2020$6,485,000
+10.8%
327,970
-26.9%
0.00%0.0%
Q3 2020$5,851,000
+39.4%
448,592
+21.2%
0.00%0.0%
Q2 2020$4,196,000
-21.4%
370,065
-0.8%
0.00%
-33.3%
Q1 2020$5,339,000
-58.6%
373,053
-21.2%
0.00%
-40.0%
Q4 2019$12,894,000
+0.8%
473,528
+6.0%
0.01%
-16.7%
Q3 2019$12,786,000
+3.2%
446,549
+0.1%
0.01%0.0%
Q2 2019$12,395,000
-23.0%
446,218
-7.9%
0.01%
-14.3%
Q1 2019$16,087,000
+10.9%
484,382
-2.9%
0.01%0.0%
Q4 2018$14,507,000
-37.3%
499,042
-0.8%
0.01%
-12.5%
Q3 2018$23,147,000
+41.2%
503,192
+14.7%
0.01%
+14.3%
Q2 2018$16,396,000
+26.8%
438,761
+0.3%
0.01%
+16.7%
Q1 2018$12,934,000
-10.8%
437,666
+3.7%
0.01%
-14.3%
Q4 2017$14,500,000
-3.6%
422,176
+1.5%
0.01%0.0%
Q3 2017$15,043,000
+39.5%
415,817
-0.4%
0.01%
+40.0%
Q2 2017$10,786,000
+54.3%
417,388
+14.6%
0.01%
+25.0%
Q1 2017$6,992,000
+343.1%
364,125
+605.8%
0.00%
+300.0%
Q2 2016$1,578,000
+431.3%
51,592
+550.7%
0.00%
Q1 2016$297,000
-20.2%
7,929
-8.0%
0.00%
Q4 2015$372,000
-86.0%
8,623
-87.9%
0.00%
-100.0%
Q3 2015$2,661,000
-27.9%
70,995
-34.6%
0.00%0.0%
Q2 2015$3,692,000
-28.6%
108,631
-25.6%
0.00%
-33.3%
Q1 2015$5,172,000
-39.7%
146,063
-42.0%
0.00%
-40.0%
Q4 2014$8,571,000
-26.7%
251,651
-17.0%
0.01%
-28.6%
Q3 2014$11,700,000
+50.5%
303,347
+51.8%
0.01%
+40.0%
Q2 2014$7,775,000
+59.5%
199,790
+40.1%
0.01%
+66.7%
Q1 2014$4,876,000
-9.5%
142,603
-44.5%
0.00%0.0%
Q4 2013$5,386,000
-66.5%
256,769
-62.5%
0.00%
-72.7%
Q3 2013$16,085,000
-14.1%
684,514
-1.8%
0.01%
-15.4%
Q2 2013$18,735,000697,2520.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 6,635,000$106,4253.51%
Glenview Capital Management 3,783,982$60,695,0711.37%
AMH Equity Ltd 47,285$758,4510.83%
DISCIPLINED GROWTH INVESTORS INC /MN 1,973,312$31,651,9240.75%
EARNEST PARTNERS LLC 3,473,281$55,711,4270.32%
AIMZ Investment Advisors, LLC 40,985$657,3990.29%
PEREGRINE CAPITAL MANAGEMENT LLC 280,767$4,503,5030.13%
Beverly Hills Private Wealth, LLC 19,687$315,7790.09%
Artisan Partners Limited Partnership 2,537,147$40,695,8380.07%
Jump Financial, LLC 84,924$1,362,1810.05%
View complete list of MYRIAD GENETICS INC shareholders